NUTEX HEALTH INC. (NUTX)

193.24USD -2.25% (-4.44)

Over 1M: +19.2%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

160 180 200
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 267.8M Q3 '25 — Operating Cash Flow: 99.5M Q3 '25 — Net Income: 55.4M Q4 '25 — Revenue: 151.7M Q4 '25 — Operating Cash Flow: 70.4M Q4 '25 — Net Income: 11.8M Q1 '26 — Revenue: 216.5M Q1 '26 — Operating Cash Flow: 75.5M Q1 '26 — Net Income: 46.8M Q2 '26 — Revenue: 210.8M Q2 '26 — Operating Cash Flow: 34.2M Q2 '26 — Net Income: 65.8M 0 60M 120M 180M 240M 300M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

8.0
ROIC 57.0%
Oper. margin 43.0%
OE margin 19.7%
SBC / sales 12.7%
Accruals -10.3%
FCF margin 32.4%
OCF margin 33.0%
ROA 18.7%
ROCE 43.0%
ROE 45.6%
Gross margin 51.3%
OCF / EBIT 0.77×

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

10.0
EV/EBIT 3.9×
EV/OE 8.6×
FCF yield 20.7%
P/E 7.4×
EV/GP 3.3×
P/C 6.4×
EV/Sales 1.7×
P/B 3.4×
Div. yield —
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
Segment HHI 0.93 HHI
RPO / sales —
RPO growth —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.1
ND/EBITDA -0.077
Debt payback 0.4 yr
Payout 0.0%
Quick ratio 5.0×
Cash / Debt 0.65×
F-score 7.0 pts
Net debt / Eq 0.28×
Debt / Eq 0.8×
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.8
Sales CAGR 4Y +27.5%
Sales/sh Y/Y -13.1%
EBIT Y/Y +52.9%
EPS Y/Y +159.1%
Sales Q/Q -13.6%
Shares change +23.0%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.